Safety Study of FSME-IMMUN NEW in Healthy Children and Adolescents Aged 1 to 15 Years

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

September 30, 2002

Study Completion Date

January 31, 2003

Conditions
Tick-borne Encephalitis
Interventions
BIOLOGICAL

FSME-IMMUN NEW 0.25 ml

Trial Locations (8)

4600

Grieskirchner Strasse 17, Wels

21100

Samodzielny Publiczny ZOZ Oddzial Dzieciecy, Lubartów

25381

Wojewodzki Szpital Dziececy oddz. Obserwacyjno-Zakazny, Kielce

31202

Szpital Jana Pawla II Odz. Neuroinfekcji, Krakow

74072

Solothurner Strasse 2, Heilbronn

77694

Hauptstraße 240, Kehl

88348

Marktplatz 3, Bad Saulgau

10-461

PANTAMED sp.z.o.o., Olsztyn

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY